Joint research agreement with BNC Korea on next gen COVID-19 vaccine

February 17th, 2022

United Immunity and BNC Korea signed a joint research agreement on United Immunity’s nanoparticle-based T cell-inducing protein vaccine technology.

Back to Press release

We want to provide you with the most important information and services in the best possible way. In order to do this, we need your consent to use the web analysis tool »Google Analytics« to create and evaluate an anonymous analysis of your visit for statistical purposes. You can change your consent at any time on the data protection page, otherwise it will remain valid for twelve months.